Bottom Line:
โ BUY SIGNAL: SNX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$224.46
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$139.37
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.0x Exit PE.
Valuation Analysis: SNX is currently trading at $158.38, which is considered fair relative to its 30-day fair value range of $154.32 to $160.16. The stock's valuation (Forward PE: 9.8) is in line with its historical norms (10.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This pessimistic expectation contrasts with the company's recent 33.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SNX is in a uptrend. Immediate support is located at $150.00, while resistance sits at $165.66.
Market Sentiment: SNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $179.91 (+14.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$154.32 -
$160.16
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
81.0%
All Signals
NEUTRAL: Price in fair range
BULLISH: Strong technical setup (60/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($179.91)
Fair Price Analysis
30-Day Fair Range
$154.32 -
$160.16
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level$150.00
Resistance Level$165.66
Current TrendUptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)9.76
Wall Street Target
$179.91
(+14.5%)
Revenue Growth (YoY)9.7%
Earnings Growth (YoY)33.1%
Profit Margin1.3%
Valuation Discount vs History
-0.7% cheaper
PE vs Historical
9.8 vs 10.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):-0.7%
(market-implied from PE analysis)
1-Year Target
$156.02
(-1%)
2-Year Target
$154.93
(-1%)
3-Year Target
$153.84
(-2%)
3-Yr Target (if PE normalizes)
(PE: 10โ10)
$157.58
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 9.8%)
$477.65
(+204%)
Base:
(SPY PE: 9.8, Growth: 9.8%)
$208.18
(+33%)
Bear:
(PE: 8.3, Growth: 9.8%)
$176.96
(+13%)
๐Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 15.35 | Current EPS (TTM): $9.95
Bull Case
$271.80
(+74%)
Analyst growth 61.7%, PE expands to 16.9
Base Case
$247.09
(+58%)
Market implied 61.7%, PE stable at 15.4
Bear Case
$103.88
(-34%)
Severe decline -20.0%, PE contracts to 13.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
๐กUpside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.8 to 10.0
Stabilization Target:
$160.93
(+2.4%)
PE Expansion Potential:
+2.4%
Share & Embed Analysis
Found this analysis useful? Share it with your community or embed the live chart on your blog.
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.